ArticleEplasty2025
Use of Continuous Topical Oxygen Therapy to Treat Lower-Extremity Surgical Wound Dehiscence: A Retrospective Review.
Article in Eplasty, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is not a singular "gold standard" therapy for managing surgical wound dehiscence (SWD); rather, the goal is expediting wound closure. This study examines the feasibility of using a continuous topical oxygen (cTOT) device as part of a treatment algorithm to treat SWD of the lower extremity. Methods: A single-center, retrospective analysis of lower-extremity SWD treated with cTOT was conducted via a retrospective chart review. Data were collected for a period of 8 months from January to August 2024. All SWD received the standard of care in addition to cTOT. Patients were seen weekly for evaluation until complete wound closure. Results: Nine patients were included in this case review. The mean patient age was 52.6 years. SWD occurred after a variety of interventions. All patients' SWD grade was either 3 or 4 according to the World Union of Wound Healing Society Sandy Grading System. The average time from starting TOT to the SWD healing was 52.6 days. In addition, the average estimated SWD surface area based on the wound measurement at the start of delivering TOT was 19.5 cm Conclusions: The positive outcomes exhibited in this case series suggest that cTOT is an effective treatment in the management of SWD in patients, regardless of specific surgical intervention. Furthermore, all the SWDs treated with cTOT progressed to wound closure without further need for surgery, hospitalization, or other costly procedures.
Indexed as
Identifiers
40778245PMC12331021What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.